COVID-19 is a new disease and there is limited information regarding risk factors for severe disease. Based on currently available information and clinical expertise, older adults and people of any age who have serious underlying medical conditions might be at higher risk for severe illness from COVID-19.
This interim guidance is based on what is currently known about the coronavirus disease 2019 (COVID-19). COVID-19 is a respiratory illness that can spread from person to person. The outbreak first started in China, but the virus continues to spread internationally and in the United States. There is much more to learn about the transmissibility, severity, and other characteristics of COVID-19 an...
COVID-19 is a new disease. Currently there are limited data and information about the impact of underlying medical conditions and whether they increase the risk for severe illness from COVID-19. Based on what we know at this time, people with the following conditions might be at an increased risk for severe illness from COVID-19:
The signs and symptoms of COVID-19 present at illness onset vary, but over the course of the disease, most people with COVID-19 experience one or more of the following: Fever or chills Cough Shortness of breath or difficulty breathing Fatigue Muscle or body aches Headache New loss of taste or smell Congestion or runny nose Nausea or vomiting Diarrhea
The adult well-male examination should provide evidence-based guidance toward the promotion of optimal health and well-being. The medical history should focus on tobacco and alcohol use, risk of human immunodeficiency virus and other sexually transmitted infections, and diet and exercise habits. The physical examination should include blood pressure screening, and height and weight measurements...
Risk Calculator to Predict Critical Illness in COVID-19 Patients
Youth use of tobacco products in any form is unsafe. If cigarette smoking continues at the current rate among youth in this country, 5.6 million of today’s Americans younger than 18 will die early from a smoking-related illness. That’s about 1 of every 13 Americans aged 17 years or younger who are alive today. CDC
In the context of community transmission where continued testing is impractical, available evidence at this time indicates that an interim strategy based on time-since-illness-onset and time-since-recovery can be implemented to establish the end of isolation. Practical application of a symptom-based strategy cannot prevent all infections.
World Health Organization (WHO)
Jan 24th, 2021 - This updated version of the Clinical management of COVID-19 guidance includes five new recommendations and a new chapter on care for patients after acute illness with COVID-19, adding to the interim guidance published 27 May 2020. Please view section text for a summary of these new recommendations, also available within each section of the guidelines, labelled as new. Other recommendations r...
National Institutes of Health (NIH)
Mar 3rd, 2021 - Tocilizumab is a recombinant humanized anti-interleukin (IL)-6 receptor monoclonal antibody approved by the Food and Drug Administration (FDA) for the treatment of certain rheumatologic disorders and cytokine release syndrome induced by chimeric antigen receptor T cell (CAR-T cell) therapy. It is hypothesized that modulating the levels of proinflammatory IL-6 or its effects may reduce the durat...
American Family Physician;
Mar 31st, 2021 - Sleep disturbances are common and likely underdiagnosed. Obstructive sleep apnea (OSA) affects up to 38% of U.S. adults, especially men, postmenopausal women, and people with a higher body mass index. Insomnia symptoms affect up to 30% of U.S. adults, with up to 10% meeting criteria for chronic insomnia disorder. The U.S. Department of Veterans Affairs and Department of Defense (VA/DoD) approve...
Kevin C. Wilson
Mar 2nd, 2016 - Coexistence of multiple chronic conditions (i. e.
American Association for Geriatric Psychiatry
Aug 31st, 1997 - Although Alzheimer's disease (AD) is currently incurable, effective treatments are available for much of the psychiatric morbidity that is commonly associated with the clinical course of AD and other dementias. Treatment of psychiatric morbidity is medically necessary to alleviate patient distress, reduce disability, diminish caregiver burden, delay institutional care, and enhance quality of li.
Dec 14th, 2014 - Research that identifies treatments that benefit patients with ICUAW is necessary to determine whether the benefits of diagnostic testing for ICUAW outweigh its burdens.
The Alzheimer's Association has partnered with government and professional organizations to develop several guidelines and recommendations that can help you care for your patients with dementia.
Gabriel T. Bosslet
May 14th, 2015 - The multisociety statement on responding to requests for potentially inappropriate treatments in intensive care units provides guidance for clinicians to prevent and manage disputes in patients with advanced critical illness.
Dec 31st, 2017 - Annual seasonal influenza vaccination remains the most effective means of protection against contracting influenza illness and preventing spread of the disease among the population. 1 Influenza infection is a significant source of morbidity and mortality in the United States.
Nov 25th, 2018 - Maintenance intravenous fluids (IVFs) are used to provide critical supportive care for children who are acutely ill. IVFs are required if sufficient fluids cannot be provided by using enteral administration for reasons such as gastrointestinal illness, respiratory compromise, neurologic impairment, a perioperative state, or being moribund from an acute or chronic illness.
Michael S. Cookson
Nov 30th, 2018 - As a direct result of the significant increase in multiple FDA-approved therapeutic agents for use in patients with metastatic castration-resistant prostate cancer (CRPC), clinicians are challenged with a multitude of treatment options and potential sequencing of these agents that, consequently, make clinical decision-making more complex. To assist in clinical decision-making, six index patient.
May 28th, 2018 - Cardiac arrest effectiveness trials have traditionally reported outcomes that focus on survival. A lack of consistency in outcome reporting between trials limits the opportunities to pool results for meta-analysis.